<h3>Gainers</h3>
<ul>
<li>Apellis Pharmaceuticals (NASDAQ:APLS) shares moved upwards by 138.8% to $40.81 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. </li>
<li>Virax Biolabs Group (NASDAQ:VRAX) shares rose 62.43% to $0.26. The market value of their outstanding shares is at $1.2 million. </li>
<li>Centessa Pharmaceuticals (NASDAQ:CNTA) stock rose 47.49% to $40.68. The market value of their outstanding shares is at $4.0 billion. </li>
<li>Insight Molecular (NASDAQ:IMDX) stock rose 34.9% to $3.44. The company's market cap stands at $82.0 million. The company's, Q4 earnings came out 3 days ago. </li>
<li>IM Cannabis (NASDAQ:IMCC) stock increased by 30.19% to $0.53. The market value of their outstanding shares is at $2.4 million. </li>
<li>Lantern Pharma (NASDAQ:LTRN) stock rose 19.83% to $1.48. The company's market cap stands at $13.8 million. The company's, Q4 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>PepGen (NASDAQ:PEPG) shares fell 48.7% to $2.17 during Tuesday's pre-market session. The company's market cap stands at $290.8 million. </li>
<li>Iterum Therapeutics (NASDAQ:ITRM) stock declined by 32.53% to $0.05. The company's market cap stands at $3.7 million. </li>
<li>Phreesia (NYSE:PHR) stock fell 24.19% to $8.65. The company's market cap stands at $687.8 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Sangamo Therapeutics (NASDAQ:SGMO) stock fell 16.73% to $0.26. The market value of their outstanding shares is at $114.2 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>BioLife Solutions (NASDAQ:BLFS) stock fell 15.87% to $15.8. The company's market cap stands at $899.6 million. </li>
<li>ImageneBio (NASDAQ:IMA) stock decreased by 14.0% to $4.3. The market value of their outstanding shares is at $55.9 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LABU

PEPG

In Tuesday's pre-market session, Apellis Pharmaceuticals saw a significant gain of 138.8%, reaching $40.81, with a market cap of $2.1 billion. Other notable gainers included Virax Biolabs (up 62.43%), Centessa Pharmaceuticals (up 47.49%), and Insight Molecular (up 34.9%). Conversely, PepGen experienced a sharp decline of 48.7%, followed by Iterum Therapeutics (down 32.53%) and Phreesia (down 24.19%). Several companies reported Q4 earnings recently, impacting stock movements.

benzinga_article

VanEck Biotech ETF

Direxion S&P Biotech Bull 3X

PepGen

Proshares Ultra Nasdaq Biotech

Insight Molecular Diagnostics

ALPS Medical Breakthrough

Health Care Select Sector SPDR

iShares US Pharma

SPDR S&P Health Equip

First Trust NYSE Arca Biotech Index Fd

iShares US Medical Devices

Phreesia

Apellis Pharma

Virax Biolabs

Invesco Nasdaq Biotechnology ETF

iShares Biotechnology ETF

Centessa Pharmaceuticals

SPDR S&P Biotech

iShares Global Healthcare

VG Health

Iterum Therap

Ark Genomic Revolution ETF

Invesco Biotechnology & Genome ETF

ITERUM THERAPEUTICS PLC

12 Health Care Stocks Moving In Tuesday's Pre-Market Session